Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1982-03-01
1984-07-31
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 23, 536 55, A61K 3170, C07H 1700
Patent
active
044629931
ABSTRACT:
The invention relates to novel aminoacridine-.alpha.,.beta.-(D)- and -(L)-N-glycoside derivatives, the salts thereof and to a novel process for the preparation of such compounds and salts. The novel compounds have the formula I ##STR1## wherein R is hydrogen or a group of the formula II ##STR2## wherein n=0 or 1, p=1 or 2, A.sup.-p is an anion, preferably halogenide, R.sup.1 is hydrogen or a methyl group and
REFERENCES:
patent: 4314061 (1982-02-01), Murdock et al.
patent: 4335244 (1982-06-01), Kaplan et al.
Studies of Optical Properties of Acridine Orange-Glucose Sulfate Complex, by K. Nishida, Y. Ando and H. Nomura.
Letter to the Editors, Wisenschaftliche Kurzberichte.
Chemical Abstracts 89:112282n (1978).
Chemical Abstracts 91:142065c (1979).
Chemical Abstracts 88:62551f (1978).
Chemical Abstracts 86:5791w (1977).
Chemical Abstracts 91:65609d (1979).
Csernus Istvan
Erdei Janos
Janossy Lorant
Kaszab Istvan
Kovacs Antal
Biogal Gyogyszergyar
Dubno Herbert
Love Ethel G.
Ross Karl F.
LandOfFree
Aminoacridine-.alpha., .beta.-(D)- or -(L)-N-glycoside derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminoacridine-.alpha., .beta.-(D)- or -(L)-N-glycoside derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoacridine-.alpha., .beta.-(D)- or -(L)-N-glycoside derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-185302